This article reviews evidence for RASI therapy in patients with advanced CKD, with the aim of enhancing GPs’ awareness to the cardiovascular and renoprotective benefits.

The unregulated implementation of risk algorithms in tools might miss identifying patients at high risk of cardiovascular disease.

Factors to be considered when assessing the burden of treatment and a patient’s capacity to cope with this workload are outlined.

In planning models of care for patients with non-communicable diseases, differences and commonalities must be considered.

A man aged 29 years presented with a 15-year history of atopic dermatitis, which started on his feet and spread to his thighs, lower abdomen, back and buttocks.

Olfactory impairment is a common condition, particularly in the geriatric population, that can be underrecognised as a result of clinician and patient unfamiliarity.

Transgender people may seek healthcare for reasons unrelated to gender, but they are often negatively impacted by structural and interpersonal discrimination in health settings.

Despite the availability of effective therapies and a national medicines subsidy scheme, a significant burden of disease still exists in Australia, with high mortality by international standards.

The aim of this study is to identify persistent symptoms in unvaccinated community-managed patients following COVID-19 infection.

Growing evidence shows that lifestyle interventions are an effective component of management for patients with mental illness to improve mental health, physical health and quality of life.

Medicare Benefits Schedule rules regarding sleep study eligibility have recently changed and incorporate validated questionnaires of obstructive sleep apnoea risk and subjective sleepiness.

MND is a group of neurodegenerative disorders best managed using a multidisciplinary approach, with the general practitioner as an integral part of the team.

Botulinum neurotoxin is an effective treatment for various movement disorders that are disabling and frequently under-recognised.

The enhanced Residential Medication Management Review program will address barriers and support general practitioners to make medication changes for older Australians.

Although not all women undergoing mastectomy will desire or choose breast reconstruction, it is important that all women have the opportunity to make an informed choice.